Moreover, TAMs enhance ovarian cancer invasiveness through activation of the nuclear factor kappa B (NF-kB) and Jun N-terminal kinase (JNK) pathways in tumor cells [58]. The gene discussed is MAPK8; the disease is ovarian carcinoma.